The Risks and Rewards of Pharmaceutical Meetings

Pharma and life sciences meetings are essential for business, but meeting managers must be careful about compliance if they want to mitigate regulatory risks. This wrap-up from our annual forum will show you how.

The eyes of the people in the audience at the opening general session of the the 7th Annual Pharmaceutical Meeting Management Forum got bigger and bigger as Thomas Forrester, who at the time was U.S. Corporate Compliance Officer, sanofi-aventis, detailed the consequences of not complying with today’s regulations—from enormous fines to criminal penalties for company ex

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish